![Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/Fierce%20Pharma%20White%20Logo_1.png?VersionId=P9fedWXoGI6vH1sYdGzXcrJPbFKuNZ77)
![Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/GenomeMedical-Logo-White-2272024.png?VersionId=Ha6poe_aSPdKbW4sJb4mNF.wKLxEISXO)
Bridging the Genetic Diagnosis Gap: Strategies for Expanding Access to Rare Disease Therapies
As targeted treatments for rare diseases rapidly emerge, genetic diagnosis plays a crucial role in enabling access to clinical trials and precision therapies with the ultimate benefit of enhancing patient outcomes.
In this panel discussion, rare disease experts discuss the significant challenges with achieving a timely and accurate rare disease diagnosis and strategies to engage both patients and providers to expand understanding of and access to therapies that benefit patients.
Speakers will address key topics including:
-
Methods to improve access to genetic diagnostics
-
Increasing provider comfort with genetic diagnoses and genetic testing to identify eligible patients
-
Strategies to boost patient awareness of clinical trials and therapies for their conditions
Join us as we explore strategic approaches employed by industry leaders, who are bridging the diagnostic gap to improve patient outcomes and accelerate the development of precision therapies.